MAST THERAPEUTICS INC's ticker is MSTX and the CUSIP is 576314108. A total of 39 filers reported holding MAST THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $125,000 | +43.7% | 1,012,559 | 0.0% | 0.00% | – |
| Q4 2016 | $87,000 | -21.6% | 1,012,559 | 0.0% | 0.00% | – |
| Q3 2016 | $111,000 | -76.6% | 1,012,559 | 0.0% | 0.00% | – |
| Q2 2016 | $475,000 | +156.8% | 1,012,559 | +49.3% | 0.00% | – |
| Q1 2016 | $185,000 | -35.1% | 678,116 | 0.0% | 0.00% | – |
| Q4 2015 | $285,000 | -27.5% | 678,116 | 0.0% | 0.00% | – |
| Q3 2015 | $393,000 | +18.4% | 678,116 | 0.0% | 0.00% | – |
| Q2 2015 | $332,000 | +22.1% | 678,116 | +20.9% | 0.00% | – |
| Q1 2015 | $272,000 | -13.4% | 560,868 | 0.0% | 0.00% | – |
| Q4 2014 | $314,000 | +0.6% | 560,868 | 0.0% | 0.00% | – |
| Q3 2014 | $312,000 | -11.4% | 560,868 | 0.0% | 0.00% | – |
| Q2 2014 | $352,000 | -7.6% | 560,868 | 0.0% | 0.00% | – |
| Q1 2014 | $381,000 | +333.0% | 560,868 | +191.6% | 0.00% | – |
| Q4 2013 | $88,000 | +4.8% | 192,325 | 0.0% | 0.00% | – |
| Q3 2013 | $84,000 | +40.0% | 192,325 | +36.5% | 0.00% | – |
| Q2 2013 | $60,000 | – | 140,873 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,294,934 | $599,000 | 0.42% |
| Ancora Advisors LLC | 1,234,599 | $571,000 | 0.09% |
| Alyeska Investment Group, L.P. | 1,900,000 | $1,757,000 | 0.07% |
| THOMPSON DAVIS & CO., INC. | 80,000 | $37,000 | 0.06% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,466,249 | $678,000 | 0.04% |
| SHEPHERD KAPLAN KROCHUK, LLC | 532,776 | $246,000 | 0.03% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 123,450 | $57,000 | 0.02% |
| WEXFORD CAPITAL LP | 89,360 | $41,000 | 0.00% |
| FRANKLIN RESOURCES INC | 12,046,100 | $5,570,000 | 0.00% |
| Renaissance Technologies | 1,535,000 | $710,000 | 0.00% |